Volume 11, Issue 2, Pages 41-46 (October 2009)

2 of 6

ABSTRACT

ABSTRACT + REFS

FULL-TEXT PDF (200 KB)

Complement Activation and Progression of Chronic Kidney Disease

Proteinuria is a strong predictor of progression in chronic kidney disease. Complement proteins are a major constituent of the urine of proteinuric patients. Complement is activated in the tubular lumen through the alternative pathway, and complement activation products are deposited on the apical surface of tubular epithelial cells. Recent animal studies have suggested that complement activation in the tubular compartment plays an important role in proteinuria-associated tubulointerstitial injury. Complement deficiency, depletion or inhibition all reduce the tubular cell damage and interstitial fibrosis that develops in proteinuric animals. In particular, inhibition of anaphylatoxin receptors protects the kidneys from proteinuria-associated damage. In this review, we discuss the evidence for a role of complement activation in the progression of chronic kidney disease.

Key words: chronic kidney disease , complement activation , proteinuria

No full text is available. To read the body of this article, please view the PDF online.

Article Outline

• Abstract

• References

• Copyright

References

1. 1 Atkins RC . The epidemiology of chronic kidney disease . Kidney Int Suppl . 2005;(94):S14–S18 .

2. 2 Stevens PE , O'Donoghue DJ , de Lusignan S , Van Vlymen J , Klebe B , Middleton R , et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results . Kidney Int . 2007;72:92–99 . MEDLINE | CrossRef

3. 3 Go AS , Chertow GM , Fan D , McCulloch CE , Hsu CY . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization . N Engl J Med . 2004;351:1296–1305 . CrossRef

4. 4 Li PK, Kwan BC, Leung CB, Kwan TH, Wong KM, Lui SL, et al. Prevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program . Kidney Int Suppl . 2005;(94):S36–S40 .

5. 5 Risdon RA , Sloper JC , De Wardener HE . Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis . Lancet . 1968;2:363–366 . Full Text | Full-Text PDF (61 KB)

6. 6 Nath KA . The tubulointerstitium in progressive renal disease . Kidney Int . 1998;54:992–994 . MEDLINE | CrossRef

7. 7 Harris RC , Neilson EG . Toward a unified theory of renal progression . Annu Rev Med . 2006;57:365–380 . MEDLINE | CrossRef

8. 8 Muller GA , Zeisberg M , Strutz F . The importance of tubulointerstitial damage in progressive renal disease . Nephrol Dial Transplant . 2000;15(Suppl 6):76–77 . CrossRef

9. 9 Wada T , Sakai N , Matsushima K , Kaneko S . Fibrocytes: a new insight into kidney fibrosis . Kidney Int . 2007;72:269–273 . CrossRef

10. 10 Iwano M , Plieth D , Danoff TM , Xue C , Okada H , Neilson EG . Evidence that fibroblasts derive from epithelium during tissue fibrosis . J Clin Invest . 2002;110:341–350 . MEDLINE | CrossRef

11. 11 Zandi-Nejad K , Eddy AA , Glassock RJ , Brenner BM . Why is proteinuria an ominous biomarker of progressive kidney disease? . Kidney Int Suppl . 2004;(92):S76–S89 .

12. 12 Remuzzi G , Benigni A , Remuzzi A . Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes . J Clin Invest . 2006;116:288–296 . MEDLINE

13. 13 GISEN Group . Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) . Lancet . 1997;349:1857–1863 . Abstract | Full Text | Full-Text PDF (104 KB) | CrossRef

14. 14 Lea J , Greene T , Hebert L , Lipkowitz M , Massry S , Middleton J , et al. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension . Arch Intern Med . 2005;165:947–953 . MEDLINE | CrossRef

15. 15 Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy . N Engl J Med . 2001;345:861–869 . MEDLINE | CrossRef

16. 16 Eddy AA . Interstitial nephritis induced by protein-overload proteinuria . Am J Pathol . 1989;135:719–733 . MEDLINE

17. 17 Olson JL , de Urdaneta AG , Heptinstall RH . Glomerular hyalinosis and its relation to hyperfiltration . Lab Invest . 1985;52:387–398 . MEDLINE

18. 18 Lai KN , Leung JC , Chan LY , Guo H , Tang SC . Interaction between proximal tubular epithelial cells and infiltrating monocytes/T cells in the proteinuric state . Kidney Int . 2007;71:526–538 . MEDLINE

19. 19 Arici M , Brown J , Williams M , Harris KP , Walls J , Brunskill NJ . Fatty acids carried on albumin modulate proximal tubular cell fibronectin production: a role for protein kinase C . Nephrol Dial Transplant . 2002;17:1751–1757 . MEDLINE | CrossRef

20. 20 Ong AC , Jowett TP , Moorhead JF , Owen JS . Human high density lipoproteins stimulate endothelin-1 release by cultured human renal proximal tubular cells . Kidney Int . 1994;46:1315–1321 . MEDLINE | CrossRef

21. 21 Honkanen E , Teppo AM , Tornroth T , Groop PH , Gronhagen-Riska C . Urinary transforming growth factor-beta 1 in membranous glomerulonephritis . Nephrol Dial Transplant . 1997;12:2562–2568 . MEDLINE | CrossRef

22. 22 Woo KT , Lau YK , Yap HK , Lee GS , Chiang GS , Lim CH . Protein selectivity: a prognostic index in IgA nephritis . Nephron . 1989;52:300–306 .

23. 23 Ogrodowski JL , Hebert LA , Sedmak D , Cosio FG , Tamerius J , Kolb W . Measurement of SC5b-9 in urine in patients with the nephrotic syndrome . Kidney Int . 1991;40:1141–1147 . MEDLINE | CrossRef

24. 24 Morita Y , Ikeguchi H , Nakamura J , Hotta N , Yuzawa Y , Matsuo S . Complement activation products in the urine from proteinuric patients . J Am Soc Nephrol . 2000;11:700–707 . MEDLINE

25. 25 Mosolits S , Magyarlaki T , Nagy J . Membrane attack complex and membrane cofactor protein are related to tubulointerstitial inflammation in various human glomerulopathies . Nephron . 1997;75:179–187 .

26. 26 Camussi G , Rotunno M , Segoloni G , Brentjens JR , Andres GA . In vitro alternative pathway activation of complement by the brush border of proximal tubules of normal rat kidney . J Immunol . 1982;128:1659–1663 . MEDLINE

27. 27 Camussi G , Tetta C , Mazzucco G , Vercellone A . The brush border of proximal tubules of normal human kidney activates the alternative pathway of the complement system in vitro . Ann N Y Acad Sci . 1983;420:321–324 . MEDLINE | CrossRef

28. 28 Baker PJ , Osofsky SG . Activation of human complement by heat- killed, human kidney cells grown in cell culture . J Immunol . 1980;124:81–86 . MEDLINE

29. 29 Biancone L , David S , Della Pietra V , Montrucchio G , Cambi V , Camussi G . Alternative pathway activation of complement by cultured human proximal tubular epithelial cells . Kidney Int . 1994;45:451–460 . MEDLINE | CrossRef

30. 30 von Zabern I , Nolte R , Vogt W . Treatment of human complement components C4 and C3 with amines or chaotropic ions. Evidence of a functional and structural change that provides uncleaved C4 and C3 with properties of their soluble activated forms, C4b and C3b . Scand J Immunol . 1981;13:413–431 . MEDLINE | CrossRef

31. 31 Nath KA , Hostetter MK , Hostetter TH . Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3 . J Clin Invest . 1985;76:667–675 . MEDLINE | CrossRef

32. 32 Peake PW , Pussell BA , Mackinnon B , Charlesworth JA . The effect of pH and nucleophiles on complement activation by human proximal tubular epithelial cells . Nephrol Dial Transplant . 2002;17:745–752 . MEDLINE | CrossRef

33. 33 Ichida S , Yuzawa Y , Okada H , Yoshioka K , Matsuo S . Localization of the complement regulatory proteins in the normal human kidney . Kidney Int . 1994;46:89–96 . MEDLINE | CrossRef

34. 34 Nangaku M , Pippin J , Couser WG . Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome . J Am Soc Nephrol . 1999;10:2323–2331 . MEDLINE

35. 35 Rangan GK , Pippin JW , Couser WG . C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis . Kidney Int . 2004;66:1838–1848 . MEDLINE | CrossRef

36. 36 Nangaku M , Pippin J , Couser WG . C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys . J Am Soc Nephrol . 2002;13:928–936 . MEDLINE

37. 37 Rangan GK , Pippin JW , Coombes JD , Couser WG . C5b-9 does not mediate chronic tubulointerstitial disease in the absence of proteinuria . Kidney Int . 2005;67:492–503 . MEDLINE | CrossRef

38. 38 Turnberg D , Lewis M , Moss J , Xu Y , Botto M , Cook HT . Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice . J Immunol . 2006;177:4094–4102 . MEDLINE

39. 39 Lenderink AM , Liegel K , Ljubanovic D , Coleman KE , Gilkeson GS , Holers VM , et al. The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy . Am J Physiol Renal Physiol . 2007;293:F555–F564 . CrossRef

40. 40 Sheerin NS , Risley P , Abe K , Tang Z , Wong W , Lin T , et al. Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury . FASEB J . 2008;22:1065–1072 . CrossRef

41. 41 Abbate M , Zoja C , Corna D , Rottoli D , Zanchi C , Azzollini N , et al. Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury . J Am Soc Nephrol . 2008;19:1158–1167 . CrossRef

42. 42 Nomura A , Morita Y , Maruyama S , Hotta N , Nadai M , Wang L , et al. Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis . Am J Pathol . 1997;151:539–547 . MEDLINE

43. 43 Morita Y , Nomura A , Yuzawa Y , Nishikawa K , Hotta N , Shimizu F , et al. The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis . J Am Soc Nephrol . 1997;8:1363–1372 . MEDLINE

44. 44 He C , Imai M , Song H , Quigg RJ , Tomlinson S . Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9 . J Immunol . 2005;174:5750–5757 . MEDLINE

45. 45 Hori Y , Yamada K , Hanafusa N , Okuda T , Okada N , Miyata T , et al. Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria . Kidney Int . 1999;56:2096–2106 . MEDLINE | CrossRef

46. 46 Nomura A , Nishikawa K , Yuzawa Y , Okada H , Okada N , Morgan BP , et al. Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement . J Clin Invest . 1995;96:2348–2356 . MEDLINE | CrossRef

47. 47 Watanabe M , Morita Y , Mizuno M , Nishikawa K , Yuzawa Y , Hotta N , et al. CD59 protects rat kidney from complement mediated injury in collaboration with crry . Kidney Int . 2000;58:1569–1579 . MEDLINE | CrossRef

48. 48 Bao L , Wang Y , Chang A , Minto AW , Zhou J , Kang H , et al. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure . J Am Soc Nephrol . 2007;18:811–822 . MEDLINE | CrossRef

49. 49 Bao L , Osawe I , Puri T , Lambris JD , Haas M , Quigg RJ . C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist . Eur J Immunol . 2005;35:2496–2506 . MEDLINE | CrossRef

50. 50 Bao L , Osawe I , Haas M , Quigg RJ . Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis . J Immunol . 2005;175:1947–1955 . MEDLINE

51. 51 Boor P , Konieczny A , Villa L , Schult AL , Bucher E , Rong S , et al. Complement C5 mediates experimental tubulointerstitial fibrosis . J Am Soc Nephrol . 2007;18:1508–1515 . MEDLINE | CrossRef

52. 52 Tang Z , Sacks S , Sheerin N . Complement acts as a mediator of renal tubulointerstitial injury . Mol Immunol . 2007;44:248; [Abstract] . CrossRef

53. 53 Tang Z , Sacks S , Sheerin NS . Innate immunity acts as a mediator of renal tubulointerstitial injury . Mol Immunol . 2007;44:3932; [Abstract] . CrossRef

54. 54 Welch TR , Frenzke M , Witte D , Davis AE . C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis . Clin Exp Immunol . 2002;130:43–48 . MEDLINE | CrossRef

55. 55 Thurman JM , Lenderink AM , Royer PA , Coleman KE , Zhou J , Lambris JD , et al. C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ischemia/reperfusion . J Immunol . 2007;178:1819–1828 . MEDLINE

56. 56 David S , Biancone L , Caserta C , Bussolati B , Cambi V , Camussi G . Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells . Nephrol Dial Transplant . 1997;12:51–56 . MEDLINE | CrossRef

57. 57 Peake PW , O'Grady S , Pussell BA , Charlesworth JA . C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor . Kidney Int . 1999;56:1729–1736 . MEDLINE | CrossRef

58. 58 Braun MC , Reins RY , Li TB , Hollmann TJ , Dutta R , Rick WA , et al. Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells . J Immunol . 2004;173:4190–4196 . MEDLINE

59. 59 Abe K , Li K , Sacks SH , Sheerin NS . The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells . Clin Exp Immunol . 2004;136:60–66 . MEDLINE | CrossRef

60. 60 Burger A , Wagner C , Hug F , Hansch GM . Up-regulation of intracellular calcium, cyclic adenosine monophosphate and fibronectin synthesis in tubular epithelial cells by complement . Eur J Immunol . 1999;29:1188–1193 . MEDLINE | CrossRef

61. 61 Li K , Patel H , Farrar CA , Hargreaves RE , Sacks SH , Zhou W . Complement activation regulates the capacity of proximal tubular epithelial cell to stimulate alloreactive T cell response . J Am Soc Nephrol . 2004;15:2414–2422 . MEDLINE | CrossRef

62. 62 Boulay F , Mery L , Tardif M , Brouchon L , Vignais P . Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells . Biochemistry . 1991;30:2993–2999 .

a Department of Nephrology, Peking University Third Hospital, Beijing, China

b Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK

Correspondence to: Dr. Neil Sheerin, School of Clinical Medical Sciences, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK. Fax: (+44) 0191-2220723

PII: S1561-5413(09)60241-6

doi:10.1016/S1561-5413(09)60241-6

2 of 6